Funding for Retinitis Pigmentosa and AMD Research at Harvard Medical School
Schepens Eye Institute at Harvard Medical School received an unrestricted grant to develop human retinal cell based therapies for eye diseases. Although the initial focus is on retinitis pigmentosa, the program will have applications for age-related macular degeneration as well.
If you found this article interesting, you can get updates in your email inbox any time similar articles are posted. The subscription options you will be presented with are based on your interest in this article. Just click here to sign up for a free membership and get started!